Novonesis (Novozymes) B
NSISBC
Classement en actions
#1146
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Prix de l'action
$71.97
Capitalisation boursière
$20.00B
Changement (1 jour)
2.66%
Changement (1 an)
13.50%
Pays
DK
Échange Novonesis (Novozymes) B (NSISBC)
Catégorie
Basic Materials
Historique du prix de l'action pour Novonesis (Novozymes) B (NSISBC)
Prix de clôture le plus élevé : $69.85 le 2026-10-01
Prix de clôture le plus bas : $58.74 le 2024-03-01
Prix de clôture le plus bas : $58.74 le 2024-03-01
Historique du prix de l'action de Novonesis (Novozymes) B de 2024 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 1.89% |
| 2025 | 7.42% |
| 2024 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $505.84 | 12.43% |
GB
|
|
| $194.66 | 6.96% |
FR
|
|
| $343.17 | 2.80% |
US
|
|
| $291.95 | 5.78% |
US
|
|
| $304.83 | 20.41% |
US
|
